All about health

Takeda Canada Inc. ("Takeda") is pleased to announce that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for a Letter of Intent (LOI) for LIVTENCITY® (maribavir) for the treatment for adults with a post-transplant...

Kane Biotech Inc. (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will release its first quarter 2024...

Cannabix Technologies Inc. (the "Company" or "Cannabix") reports that it has entered into a strategic partnership and development agreement dated May 15, 2024 (the "Agreement") with Omega Laboratories Inc of Ohio, USA ("Omega Laboratories" or...

Sunderstorm, a global family of award-winning cannabis brands, has secured strategic partnerships to launch new wellness lines in Japan. KANHA will now have a presence in two major Asian markets, Japan and Thailand, as the global brand continues its...

Today, the TSC Alliance® announced it has established the Steven Sparagana Legacy Fund to honor the upcoming retirement of Steven Sparagana, MD, who served as Tuberous Sclerosis Complex (TSC) Clinic Director at Scottish Rite for Children in Dallas...

Canopy, the first Continuous Care Platform for oncology, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, today announced a partnership to streamline continuous care...

HR Acuity, the enterprise leader in employee relations case management and investigations software, released its Eighth Annual Employee Relations Benchmark Study, providing crucial insights into the evolving landscape of workplace challenges and how...

The 2024 Intestinal Intimacy survey, conducted by Wakefield Research on behalf of IBgard®, an herbal alternative for abdominal comfort?, takes a personal look at how digestive issues can impact relationships. The survey found that 68% of respondents...

Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, has been distinguished by Fast Company as one of the Most Innovative Companies of 2024, securing a position in the...

For the fifth consecutive year, Points of Light, the world's largest nonprofit dedicated to accelerating people-powered change, named Blue Cross Blue Shield of Massachusetts (Blue Cross) an honoree of the Civic 50. Additionally, for the first time...

Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to...

Zai Lab Limited today announced that members of the Company's senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel Discussion: Thursday, May 23, 2024,...

Johnson & Johnson announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with...

Biogen Inc. and Ionis Pharmaceuticals, Inc. ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million...

HEAWELL AI's Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease ("CKD") progression when paired with Electronic Health Record ("EHR") linked...

Canopy Growth Corporation ("Canopy Growth" or the "Company") , a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ended March 31, 2024 before...

Ionis Pharmaceuticals, Inc. and Biogen Inc. announced...

Trinity Capital Inc.  ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $60 million in growth capital to Metabolon, a global leader in providing metabolomics solutions...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the results of its compatibility...

For the past 17 years, the Isabella Santos Foundation (ISF) has been at the forefront of the battle against rare pediatric cancer. Today, ISF proudly announces the public launch of the TORCH Initiative,...

Carisma Therapeutics Inc. ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the first patient was dosed in its Phase 1 clinical trial...

Liberate Bio, Inc., a company delivering genetic medicines that transcend liver-based limitations, announced an oral presentation demonstrating the success of their RAPTORtm screening platform and its first generation of extrahepatic lipid...

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, announced today the expansion of its executive leadership team with the appointment of...

New HRA Council data report shows large businesses are the fastest growing segment adopting Individual Coverage HRAs in lieu of group coverage At a glance:  Large employers with more than 200 employees are the fastest growing cohort, with adoption...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Wednesday, May 15, 2024. A total of 41.34% of...

K-Bro Linen Inc. ("K-Bro" or the "Corporation") today announces that the TSX has accepted its notice of intention to proceed with a normal course issuer bid. K-Bro's Board of Directors believes that a normal course issuer bid represents an...

International Isotopes Inc. (the "Company" or "INIS") announces its financial results for the three-month period ended March 31, 2024. Revenue for the three months ended...

An upcoming segment of Advancements with Ted Danson will focus on improvements in treatment for cancer and rare diseases. This segment will educate about Dual SMAD Inhibiting Proteins (DSIPs) ? a group of ancient growth factors, conserved across...

FX received 510k clearance for its full-wedge augmented glenoid baseplates.  The newly cleared baseplates bring 6 new options to the previously cleared portfolio.  There are now a combined total of 18 glenoid baseplate options to the market to...